Premium
Hypotensive, hypoglycaemic and hypolipidaemic effects of bioactive compounds from microalgae and marine micro‐organisms
Author(s) -
Zhao Chao,
Wu Yijing,
Yang Chengfeng,
Liu Bin,
Huang Yifan
Publication year - 2015
Publication title -
international journal of food science and technology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.831
H-Index - 96
eISSN - 1365-2621
pISSN - 0950-5423
DOI - 10.1111/ijfs.12860
Subject(s) - antiprotozoal , antiparasitic , antimicrobial , pharmacology , biology , traditional medicine , chemistry , medicine , biochemistry , microbiology and biotechnology , in vitro , pathology
Summary Microalgae and marine micro‐organisms ( MM s) have received increasing attention for the production of biologically active compounds due to their exclusive characteristics, which have adapted to the specific and extreme conditions of environments. These micro‐organisms are of considerable importance as new and promising potential sources of a huge number of natural bioactive compounds for functional foods and pharmaceutical development. Important natural bioactive compounds exhibiting a wide range of activities such as antimicrobial, antitumour, antioxidative, anti‐inflammatory, antiviral, antituberculosis, antiparasitic, anthelmintic, antimalarial, antiprotozoal, anticoagulant and antiplatelet effects have recently been isolated. To date, only a small number of MM s have been investigated for hypotensive, hypoglycaemic and hypolipidaemic activities. This study focuses specifically on revealing and discussing prospective human applications of MM s on functional foods and clinical practice and their metabolites associated with hypotensive, hypoglycaemic and hypolipidaemic activities.